| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |